Topics Antitrust Federal Court Dismisses Derivative Complaint Seeking to Impose ESG Initiatives on a Public CompanyJasper Therapeutics to Merge with Amplitude Healthcare Acquisition Corporation to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation Arbitration First of Its Kind – SEC Settles Charges Against Public Company for Misleading COVID-19 Related DisclosuresRegulators Continue to Emphasize Anti-Money Laundering Compliance Data Privacy + Cybersecurity Chinese Public Companies Confront the Risk of Delisting from U.S. Securities ExchangesRecent U.K. Cases Highlight Potential Pitfalls in Acquisition Agreements Executive compensation Watching the Backdoor: Planning for and Responding to a Cybersecurity Incident at Medical Device Companies – An FDA PerspectiveAmazon / Deliveroo Case Study Internal Documents as the Key Tool of Regulators in Merger Control Procedures Mergers + Acquisitions SEC Provides Relief for Public Company Annual Shareholder Meetings: Considerations Around Implementing Virtual MeetingsSEC Proposes to Modernize Regulation of the Use of Derivatives by Registered Investment Companies
